{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T02:10:16Z","timestamp":1734747016658,"version":"3.32.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xphs.2024.10.015","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:07:26Z","timestamp":1729256846000},"page":"2-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Professor Lynne S. Taylor: Scientist, educator, and adventurer"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-8252","authenticated-orcid":false,"given":"Dana E.","family":"Moseson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8941-4784","authenticated-orcid":false,"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8211-5607","authenticated-orcid":false,"given":"Jukka","family":"Rantanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-4323","authenticated-orcid":false,"given":"Keisuke","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-2781","authenticated-orcid":false,"given":"Geoff G.Z.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.xphs.2016.09.006","article-title":"Professor peter york-a distinguished career in powders, processing, and particle design","volume":"106","author":"Taylor","year":"2017","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0002","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/js970239m","article-title":"Characterization of the phase transitions of trehalose dihydrate on heating and subsequent dehydration","volume":"87","author":"Taylor","year":"1998","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.10.015_bib0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(98)00065-9","article-title":"Effect of particle size and temperature on the dehydration kinetics of trehalose dihydrate","volume":"167","author":"Taylor","year":"1998","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0004","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1023\/A:1011935723444","article-title":"Particle size dependent molecular rearrangements during the dehydration of trehalose dihydrate-In situ FT-Raman spectroscopy","volume":"15","author":"Taylor","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.015_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-4838(95)00142-H","article-title":"Sucrose reduces the efficiency of protein denaturation by a chaotropic agent","volume":"1253","author":"Taylor","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.015_bib0006","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/jps.24000","article-title":"George Zografi and the science of solids and surfaces","volume":"103","author":"Taylor","year":"2014","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0007","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1023\/A:1012167410376","article-title":"Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions","volume":"14","author":"Taylor","year":"1997","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.015_bib0008","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1011979221685","article-title":"The quantitative analysis of crystallinity using FT-Raman spectroscopy","volume":"15","author":"Taylor","year":"1998","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0009","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/js9800174","article-title":"Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures","volume":"87","author":"Taylor","year":"1998","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.015_bib0010","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/1520-6017(200010)89:10<1342::AID-JPS12>3.0.CO;2-X","article-title":"Evaluation of solid-state forms present in tablets by Raman spectroscopy","volume":"89","author":"Taylor","year":"2000","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.015_bib0011","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jps.1041","article-title":"Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers","volume":"90","author":"Taylor","year":"2001","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0012","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1015147729564","article-title":"A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers","volume":"19","author":"Tang","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.015_bib0013","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/ie049745u","article-title":"Crystallization monitoring by raman spectroscopy: simultaneous measurement of desupersaturation profile and polymorphic form in flufenamic acid systems","volume":"44","author":"Hu","year":"2005","journal-title":"Ind Eng Chem Res"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0014","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jps.20532","article-title":"Physical stability of crystal hydrates and their anhydrates in the presence of excipients","volume":"95","author":"Salameh","year":"2006","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jpba.2007.07.028","article-title":"Estimation of the transition temperature for an enantiotropic polymorphic system from the transformation kinetics monitored using Raman spectroscopy","volume":"45","author":"Hu","year":"2007","journal-title":"J Pharm Biomed Anal"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0016","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1002\/jps.21379","article-title":"Influence of polymeric excipients on crystal hydrate formation kinetics in aqueous slurries","volume":"97","author":"Gift","year":"2008","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0017","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jphp.12079","article-title":"Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions","volume":"66","author":"Wegiel","year":"2014","journal-title":"J Pharmacy Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.10.015_bib0018","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijpharm.2013.11.054","article-title":"Impact of sertraline salt form on the oxidative stability in powder blends","volume":"461","author":"Hsieh","year":"2014","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jps.20241","article-title":"In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy","volume":"94","author":"Wikstrom","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.015_bib0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/ac048842u","article-title":"Use of in-line near-infrared spectroscopy in combination with chemometrics for improved understanding of pharmaceutical processes","volume":"77","author":"Rantanen","year":"2005","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0021","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11095-007-9450-x","article-title":"Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients","volume":"25","author":"Wikstrom","year":"2008","journal-title":"Pharm Res"},{"issue":"13","key":"10.1016\/j.xphs.2024.10.015_bib0022","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1021\/ac100564f","article-title":"Selective detection and quantitation of organic molecule crystallization by second harmonic generation microscopy","volume":"82","author":"Wanapun","year":"2010","journal-title":"Anal Chem"},{"issue":"14","key":"10.1016\/j.xphs.2024.10.015_bib0023","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1021\/ac300917t","article-title":"Selective imaging of active pharmaceutical ingredients in powdered blends with common excipients utilizing two-photon excited ultraviolet-fluorescence and ultraviolet-second order nonlinear optical imaging of chiral crystals","volume":"84","author":"Toth","year":"2012","journal-title":"Anal Chem"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.015_bib0024","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jp3106716","article-title":"Crystallization and dissolution behavior of naproxen\/polyethylene glycol solid dispersions","volume":"117","author":"Zhu","year":"2013","journal-title":"J Phys Chem B"},{"issue":"29","key":"10.1016\/j.xphs.2024.10.015_bib0025","doi-asserted-by":"crossref","first-page":"10809","DOI":"10.1021\/jacs.1c03269","article-title":"Fluorescence-detected mid-infrared photothermal microscopy","volume":"143","author":"Li","year":"2021","journal-title":"J Am Chem Soc"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0026","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1021\/acs.molpharmaceut.2c01034","article-title":"Kinetic barriers to disproportionation of salts of weakly basic drugs","volume":"20","author":"Duong","year":"2023","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.015_bib0027","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1007\/s11095-015-1691-5","article-title":"Salt stability - the effect of pHmax on salt to free base conversion","volume":"32","author":"Hsieh","year":"2015","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0028","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11095-006-9134-y","article-title":"Effect of small levels of impurities on the water vapor sorption behavior of ranitidine HCl","volume":"24","author":"Guerrieri","year":"2007","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0029","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s11095-009-9918-y","article-title":"Role of salt and excipient properties on disproportionation in the solid-state","volume":"26","author":"Guerrieri","year":"2009","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/acs.molpharmaceut.7b00694","article-title":"Impact of solid-state form on the disproportionation of miconazole mesylate","volume":"15","author":"Patel","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0031","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1111\/j.1365-2621.2006.tb12392.x","article-title":"Deliquescence lowering in food ingredient mixtures","volume":"71","author":"Salameh","year":"2006","journal-title":"J Food Sci"},{"key":"10.1016\/j.xphs.2024.10.015_bib0032","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.food.080708.100915","article-title":"Water-solids interactions: deliquescence","volume":"1","author":"Mauer","year":"2010","journal-title":"Annu Rev Food Sci Technol"},{"key":"10.1016\/j.xphs.2024.10.015_bib0033","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3109\/10837450903397594","article-title":"Deliquescence of pharmaceutical systems","volume":"15","author":"Mauer","year":"2010","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2024.10.015_bib0034","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.foodchem.2013.02.123","article-title":"Water-solid interactions between amorphous maltodextrins and crystalline sodium chloride","volume":"144","author":"Ghorab","year":"2014","journal-title":"Food Chem"},{"issue":"51","key":"10.1016\/j.xphs.2024.10.015_bib0035","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1021\/acs.jafc.7b04746","article-title":"Effects of chloride and sulfate salts on the inhibition or promotion of sucrose crystallization in initially amorphous sucrose-salt blends","volume":"65","author":"Thorat","year":"2017","journal-title":"J Agric Food Chem"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.015_bib0036","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1021\/jf200203n","article-title":"Degradation kinetics of catechins in green tea powder: effects of temperature and relative humidity","volume":"59","author":"Li","year":"2011","journal-title":"J Agric Food Chem"},{"issue":"51","key":"10.1016\/j.xphs.2024.10.015_bib0037","doi-asserted-by":"crossref","first-page":"12531","DOI":"10.1021\/jf304116s","article-title":"Kinetic study of catechin stability: effects of pH, concentration, and temperature","volume":"60","author":"Li","year":"2012","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.xphs.2024.10.015_bib0038","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.foodres.2018.06.056","article-title":"Chemical stability and reaction kinetics of two thiamine salts (thiamine mononitrate and thiamine chloride hydrochloride) in solution","volume":"112","author":"Voelker","year":"2018","journal-title":"Food Res Int"},{"key":"10.1016\/j.xphs.2024.10.015_bib0039","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s11095-006-9063-9","article-title":"Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility","volume":"23","author":"Marsac","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.015_bib0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11095-008-9721-1","article-title":"Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters","volume":"26","author":"Marsac","year":"2009","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.015_bib0041","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s11095-006-9047-9","article-title":"A comparison of the physical stability of amorphous felodipine and nifedipine systems","volume":"23","author":"Marsac","year":"2006","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0042","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/jps.20697","article-title":"Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine","volume":"95","author":"Konno","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.015_bib0043","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11095-007-9331-3","article-title":"Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture","volume":"25","author":"Konno","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.015_bib0044","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s11095-009-9974-3","article-title":"Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions","volume":"26","author":"Rumondor","year":"2009","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0045","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1039\/c001905d","article-title":"Role of polymer chemistry in influencing crystal growth rates from amorphous felodipine","volume":"12","author":"Kestur","year":"2010","journal-title":"CrystEngComm"},{"issue":"20","key":"10.1016\/j.xphs.2024.10.015_bib0046","doi-asserted-by":"crossref","DOI":"10.1039\/c1ce05183k","article-title":"An ab initio polymer selection methodology to prevent crystallization in amorphous solid dispersions by application of crystal engineering principles","volume":"13","author":"Van Eerdenbrugh","year":"2011","journal-title":"CrystEngComm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0047","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jps.23358","article-title":"Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers","volume":"102","author":"Wegiel","year":"2013","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.10.015_bib0048","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2013.11.057","article-title":"Impact of surfactants on the crystal growth of amorphous celecoxib","volume":"461","author":"Mosquera-Giraldo","year":"2014","journal-title":"Int J Pharm"},{"issue":"33","key":"10.1016\/j.xphs.2024.10.015_bib0049","doi-asserted-by":"crossref","first-page":"9974","DOI":"10.1021\/jp504450h","article-title":"Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds","volume":"118","author":"Trasi","year":"2014","journal-title":"J Phys Chem B"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.015_bib0050","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1002\/jps.22197","article-title":"A classification system to assess the crystallization tendency of organic molecules from undercooled melts","volume":"99","author":"Baird","year":"2010","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.015_bib0051","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1002\/jps.22214","article-title":"Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation - Classification and comparison with crystallization tendency from undercooled melts","volume":"99","author":"Van Eerdenbrugh","year":"2010","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0052","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11095-011-0540-4","article-title":"Role of viscosity in influencing the glass-forming ability of organic molecules from the undercooled melt state","volume":"29","author":"Baird","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.015_bib0053","first-page":"47","article-title":"Phase behavior of poly (vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture","volume":"86","author":"Rumondor","year":"2009","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0054","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1208\/s12249-011-9686-y","article-title":"Understanding the tendency of amorphous solid dispersions to undergo amorphous-amorphous phase separation in the presence of absorbed moisture","volume":"12","author":"Rumondor","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.015_bib0055","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1021\/acs.molpharmaceut.5b00041","article-title":"Phase separation kinetics in amorphous solid dispersions upon exposure to water","volume":"12","author":"Purohit","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0056","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1007\/s11095-017-2265-5","article-title":"Phase behavior of ritonavir amorphous solid dispersions during hydration and dissolution","volume":"34","author":"Purohit","year":"2017","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.015_bib0057","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/jps.23099","article-title":"Nanoscale mid-infrared imaging of phase separation in a drug-polymer blend","volume":"101","author":"Van Eerdenbrugh","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.015_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121708","article-title":"Phase separation in surfactant-containing amorphous solid dispersions: orthogonal analytical methods to probe the effects of surfactants on morphology and phase composition","volume":"619","author":"Yang","year":"2022","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0059","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/acs.molpharmaceut.5b00925","article-title":"Nanoscale infrared, thermal, and mechanical characterization of telaprevir-polymer miscibility in amorphous solid dispersions prepared by solvent evaporation","volume":"13","author":"Li","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0060","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1021\/acs.molpharmaceut.7b00499","article-title":"Insights into water-induced phase separation in itraconazole-hydroxypropylmethyl cellulose spin coated and spray dried dispersions","volume":"14","author":"Mugheirbi","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0061","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.molpharmaceut.6b01151","article-title":"Understanding the impact of water on the miscibility and microstructure of amorphous solid dispersions: an AFM-LCR and TEM-EDX study","volume":"14","author":"Li","year":"2017","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.015_bib0062","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s11095-017-2145-z","article-title":"Insights into nano- and micron-scale phase separation in amorphous solid dispersions using fluorescence-based techniques in combination with solid state nuclear magnetic resonance spectroscopy","volume":"34","author":"Purohit","year":"2017","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.015_bib0063","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1021\/acs.molpharmaceut.6b00803","article-title":"Investigating the correlation between miscibility and physical stability of amorphous solid dispersions using fluorescence-based techniques","volume":"13","author":"Tian","year":"2016","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0064","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1021\/acs.cgd.8b01435","article-title":"Nanometer-scale residual crystals in a hot melt extruded amorphous solid dispersion: characterization by transmission electron microscopy","volume":"18","author":"Moseson","year":"2018","journal-title":"Cryst Growth Des"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0065","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11095-013-1216-z","article-title":"Classification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments","volume":"31","author":"Van Eerdenbrugh","year":"2014","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.015_bib0066","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1007\/s11095-012-0759-8","article-title":"PH-Induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties","volume":"29","author":"Hsieh","year":"2012","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0067","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1021\/cg201590j","article-title":"Characterizing the impact of hydroxypropylmethyl cellulose on the growth and nucleation kinetics of felodipine from supersaturated solutions","volume":"12","author":"Alonzo","year":"2012","journal-title":"Cryst Growth Des"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.015_bib0068","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1021\/cg300325p","article-title":"Understanding polymer properties important for crystal growth inhibition\u2014impact of chemically diverse polymers on solution crystal growth of ritonavir","volume":"12","author":"Ilevbare","year":"2012","journal-title":"Cryst Growth Des"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0069","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1021\/cg301447d","article-title":"Maintaining supersaturation in aqueous drug solutions: Impact of different polymers on induction times","volume":"13","author":"Ilevbare","year":"2013","journal-title":"Cryst Growth Des"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.015_bib0070","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1021\/mp400029v","article-title":"Impact of polymers on crystal growth rate of structurally diverse compounds from aqueous solution","volume":"10","author":"Ilevbare","year":"2013","journal-title":"Mol Pharm"},{"issue":"41","key":"10.1016\/j.xphs.2024.10.015_bib0071","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.1021\/acs.langmuir.5b02486","article-title":"Influence of polymers on the crystal growth rate of felodipine: correlating adsorbed polymer surface coverage to solution crystal growth inhibition","volume":"31","author":"Schram","year":"2015","journal-title":"Langmuir"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0072","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acs.cgd.5b01779","article-title":"Polymer inhibition of crystal growth by surface poisoning","volume":"16","author":"Schram","year":"2016","journal-title":"Crystal Growth Design"},{"key":"10.1016\/j.xphs.2024.10.015_bib0073","doi-asserted-by":"crossref","first-page":"126254","DOI":"10.1016\/j.jcrysgro.2021.126254","article-title":"Beaudoin SP Polymer effects on crystallization at the amorphous atazanavir-water interface","volume":"571","author":"Parker","year":"2021","journal-title":"J Cryst Growth"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.015_bib0074","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1021\/acs.cgd.5b00392","article-title":"Bile salts as crystallization inhibitors of supersaturated solutions of poorly water-soluble compounds","volume":"15","author":"Chen","year":"2015","journal-title":"Cryst Growth Des"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0075","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1021\/acs.cgd.6b01470","article-title":"A comparison of the crystallization inhibition properties of bile salts","volume":"16","author":"Li","year":"2016","journal-title":"Cryst Growth Des"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.015_bib0076","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/acs.cgd.7b00237","article-title":"Maintaining supersaturation of active pharmaceutical ingredient solutions with biologically relevant bile salts","volume":"17","author":"Lu","year":"2017","journal-title":"Cryst Growth Des"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0077","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1021\/acs.cgd.9b00482","article-title":"Impact of monomeric versus micellar surfactant and surfactant-polymer interactions on nucleation-induction times of atazanavir from supersaturated solutions","volume":"20","author":"Indulkar","year":"2020","journal-title":"Cryst Growth Des"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0078","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/acs.molpharmaceut.7b00814","article-title":"Variation in supersaturation and phase behavior of ezetimibe amorphous solid dispersions upon dissolution in different biorelevant media","volume":"15","author":"Elkhabaz","year":"2018","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.015_bib0079","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1021\/acs.cgd.0c01730","article-title":"Crystallization kinetics in fasted-state simulated and aspirated human intestinal fluids","volume":"21","author":"Elkhabaz","year":"2021","journal-title":"Cryst Growth Des"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0080","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11095-009-0021-1","article-title":"Understanding the behavior of amorphous pharmaceutical systems during dissolution","volume":"27","author":"Alonzo","year":"2010","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0081","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/jps.22579","article-title":"Dissolution and precipitation behavior of amorphous solid dispersions","volume":"100","author":"Alonzo","year":"2011","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0082","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11095-015-1823-y","article-title":"Dissolution performance of high drug loading celecoxib amorphous solid dispersions formulated with polymer combinations","volume":"33","author":"Xie","year":"2016","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0083","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/acs.molpharmaceut.5b00652","article-title":"Dissolution of danazol amorphous solid dispersions: supersaturation and phase behavior as a function of drug loading and polymer type","volume":"13","author":"Jackson","year":"2016","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.015_bib0084","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.xphs.2016.03.024","article-title":"Non-sink dissolution conditions for predicting product quality and in vivo performance of supersaturating drug delivery systems","volume":"105","author":"Sun","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.015_bib0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2016.03.006","article-title":"Physical chemistry of supersaturated solutions and implications for oral absorption","volume":"101","author":"Taylor","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0086","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1021\/cg301679h","article-title":"Liquid-liquid phase separation in highly supersaturated aqueous solutions of poorly water-soluble drugs: implications for solubility enhancing formulations","volume":"13","author":"Ilevbare","year":"2013","journal-title":"Crystal Growth Design"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0087","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp500573z","article-title":"Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir","volume":"12","author":"Mosquera-Giraldo","year":"2015","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.015_bib0088","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1021\/acs.molpharmaceut.5b00056","article-title":"pH-dependent liquid-liquid phase separation of highly supersaturated solutions of weakly basic drugs","volume":"12","author":"Indulkar","year":"2015","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0089","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.xphs.2017.04.015","article-title":"Origin of nanodroplet formation upon dissolution of an amorphous solid dispersion: a mechanistic isotope scrambling study","volume":"106","author":"Indulkar","year":"2017","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.015_bib0090","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/jps.23826","article-title":"Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs","volume":"103","author":"Raina","year":"2014","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.015_bib0091","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1021\/acs.molpharmaceut.6b00202","article-title":"Exploiting the phenomenon of liquid-liquid phase separation for enhanced and sustained membrane transport of a poorly water-soluble drug","volume":"13","author":"Indulkar","year":"2016","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0092","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/mp500571m","article-title":"Assessment of the amorphous \"solubility\" of a group of diverse drugs using new experimental and theoretical approaches","volume":"12","author":"Almeida E Sousa","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0093","article-title":"Amorphous solubility advantage: theoretical considerations, experimental methods, and contemporary relevance","author":"Ueda","year":"2024","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0094","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/jps.24528","article-title":"Thermodynamics of highly supersaturated aqueous solutions of poorly water-soluble drugs - impact of a second drug on the solution phase behavior and implications for combination products","volume":"104","author":"Trasi","year":"2015","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.015_bib0095","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1007\/s11095-015-1712-4","article-title":"Impact of solubilizing additives on supersaturation and membrane transport of drugs","volume":"32","author":"Raina","year":"2015","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0096","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1021\/acs.molpharmaceut.9b00956","article-title":"Interplay of supersaturation and solubilization: lack of correlation between concentration-based supersaturation measurements and membrane transport rates in simulated and aspirated human fluids","volume":"16","author":"Elkhabaz","year":"2019","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0097","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/acs.molpharmaceut.0c00061","article-title":"Polymer type impacts amorphous solubility and drug-rich phase colloidal stability: a mechanistic study using nuclear magnetic resonance spectroscopy","volume":"17","author":"Ueda","year":"2020","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.015_bib0098","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1021\/acs.molpharmaceut.7b00740","article-title":"Absorptive dissolution testing of supersaturating systems: impact of absorptive sink conditions on solution phase behavior and mass transport","volume":"14","author":"Hate","year":"2017","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0099","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/acs.molpharmaceut.8b01117","article-title":"Insight into amorphous solid dispersion performance by coupled dissolution and membrane mass transfer measurements","volume":"16","author":"Hate","year":"2019","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0100","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.molpharmaceut.8b01261","article-title":"Insights into the dissolution mechanism of ritonavir-copovidone amorphous solid dispersions: importance of congruent release for enhanced performance","volume":"16","author":"Indulkar","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0101","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.039","article-title":"Congruent release of drug and polymer: a \"sweet spot\" in the dissolution of amorphous solid dispersions","volume":"298","author":"Saboo","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2024.10.015_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105514","article-title":"Patterns of drug release as a function of drug loading from amorphous solid dispersions: a comparison of five different polymers","volume":"155","author":"Saboo","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0103","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/acs.molpharmaceut.1c00481","article-title":"Balancing solid-state stability and dissolution performance of lumefantrine amorphous solid dispersions: the role of polymer choice and drug-polymer interactions","volume":"19","author":"Hiew","year":"2022","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0104","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/acs.molpharmaceut.3c01106","article-title":"Interplay of drug-polymer interactions and release performance for HPMCAS-based amorphous solid dispersions","volume":"21","author":"Bapat","year":"2024","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0105","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1021\/acs.molpharmaceut.9b01025","article-title":"Insights into the dissolution behavior of ledipasvir-copovidone amorphous solid dispersions: role of drug loading and intermolecular interactions","volume":"16","author":"Que","year":"2019","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0106","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/acs.molpharmaceut.9b01272","article-title":"Congruent release of drug and polymer from amorphous solid dispersions: insights into the role of drug-polymer hydrogen bonding, surface crystallization and glass transition","volume":"17","author":"Saboo","year":"2020","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.015_bib0107","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acs.molpharmaceut.1c00419","article-title":"Impact of drug-polymer intermolecular interactions on dissolution performance of copovidone-based amorphous solid dispersions","volume":"18","author":"Que","year":"2021","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0108","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11095-022-03183-4","article-title":"Role of surfactants on release performance of amorphous solid dispersions of ritonavir and copovidone","volume":"39","author":"Indulkar","year":"2022","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0109","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11095-023-03483-3","article-title":"Release enhancement by plasticizer inclusion for amorphous solid dispersions containing high Tg drugs","volume":"40","author":"Correa-Soto","year":"2023","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.xphs.2022.10.021","article-title":"Release mechanisms of amorphous solid dispersions: role of drug-polymer phase separation and morphology","volume":"112","author":"Yang","year":"2023","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0111","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/acs.molpharmaceut.3c00020","article-title":"Dissolution mechanisms of amorphous solid dispersions: a close look at the dissolution interface","volume":"20","author":"Deac","year":"2023","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0112","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1021\/acs.molpharmaceut.3c01179","article-title":"Dissolution mechanisms of amorphous solid dispersions: application of ternary phase diagrams to explain release behavior","volume":"21","author":"Deac","year":"2024","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.015_bib0113","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/pharmaceutics13050735","article-title":"Exploring the role of surfactants in enhancing drug release from amorphous solid dispersions at higher drug loadings","volume":"13","author":"Saboo","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0114","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11095-022-03183-4","article-title":"Role of surfactants on release performance of amorphous solid dispersions of ritonavir and copovidone","volume":"39","author":"Indulkar","year":"2022","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.xphs.2022.03.020","article-title":"Formulation and processing strategies which underpin susceptibility to matrix crystallization in amorphous solid dispersions","volume":"112","author":"Moseson","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.015_bib0116","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s11095-023-03502-3","article-title":"Drug release from surfactant-containing amorphous solid dispersions: mechanism and role of surfactant in release enhancement","volume":"40","author":"Yang","year":"2023","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.015_bib0117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2022.04.002","article-title":"Combining enabling formulation strategies to generate supersaturated solutions of delamanid: In situ salt formation during amorphous solid dispersion fabrication for more robust release profiles","volume":"174","author":"Duong","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0118","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2022.09.056","article-title":"Combining drug salt formation with amorphous solid dispersions - a double edged sword","volume":"352","author":"Hiew","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2024.10.015_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121886","article-title":"Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation","volume":"622","author":"Qi","year":"2022","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.015_bib0120","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s11095-016-1913-5","article-title":"Leaching of lopinavir amorphous solid dispersions in acidic media","volume":"33","author":"Li","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.015_bib0121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2018.04.014","article-title":"Tailoring supersaturation from amorphous solid dispersions","volume":"279","author":"Li","year":"2018","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0122","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/acs.molpharmaceut.2c00895","article-title":"Impact of gastric pH variations on the release of amorphous solid dispersion formulations containing a weakly basic drug and enteric polymers","volume":"20","author":"Nguyen","year":"2023","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.015_bib0123","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1021\/acs.cgd.0c00073","article-title":"Evidence for halogen bonding in amorphous solid dispersions","volume":"20","author":"Que","year":"2020","journal-title":"Cryst Growth Des"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0124","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.carbpol.2013.07.017","article-title":"Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices","volume":"98","author":"Li","year":"2013","journal-title":"Carbohydr Polym"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.015_bib0125","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1021\/mp400441d","article-title":"Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions","volume":"10","author":"Pereira","year":"2013","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.015_bib0126","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1021\/acs.biomac.6b01156","article-title":"Mechanistic design of chemically diverse polymers with applications in oral drug delivery","volume":"17","author":"Mosquera-Giraldo","year":"2016","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0127","doi-asserted-by":"crossref","first-page":"18535","DOI":"10.1038\/s41598-020-75077-7","article-title":"Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance","volume":"10","author":"Wilson","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2024.10.015_bib0128","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119680","article-title":"Designing synergistic crystallization inhibitors: bile salt derivatives of cellulose with enhanced hydrophilicity","volume":"292","author":"Novo","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2024.10.015_bib0129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2018.11.003","article-title":"Relationship between amorphous solid dispersion In Vivo absorption and In Vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport","volume":"292","author":"Wilson","year":"2018","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.015_bib0130","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1021\/acs.molpharmaceut.3c00174","article-title":"Fed- and fasted-state performance of pretomanid amorphous solid dispersions formulated with an enteric polymer","volume":"20","author":"Nguyen","year":"2023","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0131","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1021\/acs.molpharmaceut.8b00324","article-title":"Phase behavior of drug-hydroxypropyl methylcellulose amorphous solid dispersions produced from various solvent systems: mechanistic understanding of the role of polymer using experimental and theoretical methods","volume":"15","author":"Mugheirbi","year":"2018","journal-title":"Mol Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.10.015_bib0132","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.02.005","article-title":"Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion","volume":"540","author":"Bhardwaj","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0133","article-title":"Amorphous solid dispersion formation via solvent granulation - a case study with ritonavir and lopinavir","volume":"1","author":"Trasi","year":"2019","journal-title":"Int J Pharm X"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.015_bib0134","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1021\/acs.molpharmaceut.0c00798","article-title":"Water-induced phase separation of spray-dried amorphous solid dispersions","volume":"17","author":"Li","year":"2020","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.015_bib0135","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.xphs.2020.12.033","article-title":"Physical stability and dissolution of lumefantrine amorphous solid dispersions produced by spray anti-solvent precipitation","volume":"110","author":"Bhujbal","year":"2021","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0136","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.xphs.2022.12.019","article-title":"Improving dissolution performance and drug loading of amorphous dispersions through a hierarchical particle approach","volume":"112","author":"Hiew","year":"2023","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.10.015_bib0137","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijpharm.2018.10.055","article-title":"The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity","volume":"553","author":"Moseson","year":"2018","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0138","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/acs.cgd.3c01147","article-title":"Orthogonal analytical methods to elucidate how low levels of residual crystallinity in posaconazole amorphous solid dispersions impact phase behavior during release","volume":"24","author":"Shah","year":"2024","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2024.10.015_bib0139","article-title":"Surface nanocoating of high drug-loading spray-dried amorphous solid","volume":"620","author":"Duong","year":"2022","journal-title":"Int J Pharm"},{"issue":"36","key":"10.1016\/j.xphs.2024.10.015_bib0140","doi-asserted-by":"crossref","first-page":"40698","DOI":"10.1021\/acsami.2c12666","article-title":"Atomic layer coating to inhibit surface crystallization of amorphous pharmaceutical powders","volume":"14","author":"Moseson","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.015_bib0141","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1021\/acs.molpharmaceut.3c00526","article-title":"Crystallinity: a complex critical quality attribute of amorphous solid dispersions","volume":"20","author":"Moseson","year":"2023","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.015_bib0142","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.xphs.2016.09.016","article-title":"Non-sink dissolution behavior and solubility limit of commercial tacrolimus amorphous formulations","volume":"106","author":"Trasi","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.015_bib0143","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s11095-017-2221-4","article-title":"Evaluation of the crystallization tendency of commercially available amorphous tacrolimus formulations exposed to different stress conditions","volume":"34","author":"Trasi","year":"2017","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.015_bib0144","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.xphs.2017.12.024","article-title":"Investigating the impact of drug crystallinity in amorphous tacrolimus capsules on pharmacokinetics and bioequivalence using discriminatory in vitro dissolution testing and physiologically based pharmacokinetic modeling and simulation","volume":"107","author":"Purohit","year":"2018","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.015_bib0145","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1021\/acs.molpharmaceut.9b00455","article-title":"Assessing the impact of endogenously derived crystalline drug on the in vivo performance of amorphous formulations","volume":"16","author":"Purohit","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.015_bib0146","article-title":"Changes in drug crystallinity in a commercial tacrolimus amorphous formulation result in variable pharmacokinetics","author":"Taylor","year":"2024","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0147","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/acs.cgd.7b01521","article-title":"Paclitaxel crystal seeds with different intrinsic properties and their impact on dissolution of paclitaxel-HPMCAS amorphous solid dispersions","volume":"18","author":"Que","year":"2018","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2024.10.015_bib0148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105276","article-title":"Amorphous solid dispersions containing residual crystallinity: Influence of seed properties and polymer adsorption on dissolution performance","volume":"146","author":"Moseson","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0149","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1208\/s12248-021-00598-6","article-title":"Amorphous solid dispersions containing residual crystallinity: competition between dissolution and matrix crystallization","volume":"23","author":"Moseson","year":"2021","journal-title":"AAPS J"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.015_bib0150","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1021\/acs.molpharmaceut.1c00679","article-title":"Work-life balance in the pharmaceutical sciences: more essential than ever today","volume":"18","author":"Taylor","year":"2021","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0151","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/acs.molpharmaceut.2c00018","article-title":"Review of the picture a scientist documentary","volume":"19","author":"Taylor","year":"2022","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.015_bib0152","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1021\/acs.molpharmaceut.2c00118","article-title":"The myth of meritocracy in the pharmaceutical sciences","volume":"19","author":"Taylor","year":"2022","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.015_bib0153","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1021\/acs.molpharmaceut.2c00600","article-title":"Structured sponsorship: an option for improved workplace inclusion in the pharmaceutical sciences","volume":"19","author":"Law","year":"2022","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.015_bib0154","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1021\/acs.molpharmaceut.2c00625","article-title":"Faking it: impostor syndrome in the pharmaceutical sciences","volume":"19","author":"Taylor","year":"2022","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.015_bib0155","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1021\/acs.molpharmaceut.3c00036","article-title":"Building a culture of diversity, equity, inclusion, and respect in the pharmaceutical sciences","volume":"20","author":"Taylor","year":"2023","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.015_bib0156","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/acs.molpharmaceut.4c00267","article-title":"Networking in the pharmaceutical sciences","volume":"21","author":"Taylor","year":"2024","journal-title":"Mol Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T01:36:23Z","timestamp":1734744983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924004544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022354924004544"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.015","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Professor Lynne S. Taylor: Scientist, educator, and adventurer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}